Clinical Trials Logo

Skin Ulcer Venous Stasis Chronic clinical trials

View clinical trials related to Skin Ulcer Venous Stasis Chronic.

Filter by:
  • None
  • Page 1

NCT ID: NCT04971161 Recruiting - Clinical trials for Skin Ulcer Venous Stasis Chronic

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of CVU (Phase IIb)

Start date: August 18, 2021
Phase: Phase 2
Study type: Interventional

The aim of this clinical trial is to investigate the efficacy (by monitoring the wound size reduction of CVUs) and safety (by monitoring adverse events [AEs]) of three dose groups of the investigational medicinal product (IMP) allo-APZ2-CVU, topically administered on target wounds of patients with CVU compared to placebo.

NCT ID: NCT03257098 Completed - Clinical trials for Skin Ulcer Venous Stasis Chronic

Allogeneic ABCB5-positive Stem Cells for Treatment of CVU

Start date: November 16, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this clinical trial is to investigate the efficacy (by monitoring the wound size reduction of Chronic Venous Ulcers) and safety (by monitoring adverse events) of the medicinal product to be studied after two applications on the wound surface in patients with Chronic Venous Ulcers.

NCT ID: NCT02742844 Terminated - Clinical trials for Skin Ulcer Venous Stasis Chronic

Clinical Trial to Investigate Efficacy and Safety of the IMP in Patients With Non Healing Wounds Originating From Ulcers

Start date: August 2016
Phase: Phase 1/Phase 2
Study type: Interventional

The aim of this clinical trial is to investigate the efficacy (by monitoring the wound size reduction) and safety (by monitoring occurring adverse events) of the investigational medicinal product APZ2 after one single application on chronic venous leg ulcer wounds.

NCT ID: NCT02307448 Terminated - Pressure Ulcer Clinical Trials

Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Non-Healing Wounds

Start date: August 2015
Phase: N/A
Study type: Interventional

This investigation plans to initiate the healing of chronic wounds by providing a concentrated platelet and growth factor therapy directly to the wound site by topical delivery. This therapy will be derived from autologous platelet rich plasma (PRP), an emerging surgical and wound care treatment. This investigation aims to demonstrate that patients with chronic, non-healing wounds treated with autologous PRP and standard medical care have a reduction in wound volume and improved healing rate that results in patient-centered clinically significant health outcomes as compared to patients treated with standard medical care only.

NCT ID: NCT01913704 Withdrawn - Clinical trials for Skin Ulcer Venous Stasis Chronic

Pilot Study Comparing NatroxTM Topical Oxygen Therapy to A Placebo in the Management of Non-Healing Leg Ulcers

Start date: October 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effectiveness of the NatroxTM Topical Oxygen device versus a placebo in patients with non-healing leg ulceration in conjunction with standard best practice.